INMB vs RMD · rev $50.0K vs P/E 29, rev $5.65B
INmune Bio Inc (INMB) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
INMB currently screens at market cap $33.5M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the INMB and RMD stock pages for the full models.
Not investment advice.